IL6 and rheumatoid arthritis: Although the etiologies of rheumatoid arthritis (RA) are not fully understood, proinflammatory cytokines such as tumor necrosis factor- (TNF-) α, interleukin- (IL-) 1, and IL-6 have been shown to play a role in the pathology of RA and, as such, are potential therapeutic targets [1].